Standard Biotools (LAB) Change in Receivables (2010 - 2026)

Standard Biotools (LAB) has 17 years of Change in Receivables data on file, last reported at $1.9 million in Q1 2026.

• On a quarterly basis, Change in Receivables fell 8.07% year-over-year to $1.9 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 119.14% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 115.18% from the prior year.
• Change in Receivables for Q1 2026 stood at $1.9 million, up from -$6.7 million in the prior quarter.
• Over the last five years, Change in Receivables for LAB reached as high as $6.2 million in Q3 2022 and fell as low as -$6.7 million in Q4 2025.
• Historically, Change in Receivables has averaged -$224705.9 across 5 years, with a median of $276000.0 in 2025.
• Across the five-year window, Change in Receivables soared 6013.33% in 2023 and slumped 648.29% in 2024, its largest moves.
• Year by year, Change in Receivables stood at $60000.0 in 2022, then surged by 6013.33% to $3.7 million in 2023, then tumbled by 282.52% to -$6.7 million in 2024, then slipped by 0.52% to -$6.7 million in 2025, then jumped by 127.61% to $1.9 million in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were $1.9 million in Q1 2026, -$6.7 million in Q4 2025, and $5.8 million in Q3 2025.